Madan A, Parkinson A, Faiman M D
Department of Pharmacology and Toxicology, University of Kansas, Lawrence 66045, USA.
Alcohol Clin Exp Res. 1998 Sep;22(6):1212-9.
Diethyldithiocarbamate methyl ester (DDTC-Me) is a precursorto the formation of S-methyl-N,N-diethylthiolcarbamate sulfoxide, the active metabolite proposed to be responsible for the alcohol deterrent effects of disulfiram. The present study investigated the role of human cytochrome P-450 (CYP) enzymes in sulfoxidation and thiono-oxidation of DDTC-Me, intermediary steps in the activation of disulfiram. Several approaches were used in an attempt to delineate the particular P-450 enzyme(s) involved in the sulfoxidation and thiono-oxidation of DDTC-Me. These approaches included the use of cDNA-expressed human P-450 enzymes, correlation analysis with sample-to-sample variation in human P-450 enzymes in a bank of human liver microsomes, and chemical and antibody inhibition studies. Multiple human P-450 enzymes (CYP3A4, CYP1A2, CYP2A6, and CYP2D6) catalyzed the sulfoxidation of DDTC-Me, as determined with cDNA-expressed enzymes. Several lines of evidence suggest that the sulfoxidation of DDTC-Me by human liver microsomes is primarily catalyzed by CYP3A4/5, including (1) a high correlation between DDTC-Me sulfoxidation and testosterone 6beta-hydroxylation; (2) increased DDTC-Me sulfoxidation in the presence of alpha-naphthoflavone, an activator of CYP3A enzymes; (3) inhibition of this reaction by inhibitors of CYP3A4/5 enzymes, such as troleandomycin and ketoconazole; and (4) inhibition of DDTC-Me sulfoxidation by antibodies against CYP3A enzymes. On the other hand, several lines of evidence suggested that the thiono-oxidation of DDTC-Me by human liver microsomes is catalyzed in part by CYP1A2, CYP2B6, CYP2E1, and CYP3A4/5, including (1) these human P450 enzymes among others have the capacity to catalyze this reaction, as determined with cDNA-expressed enzymes; (2) a high correlation between DDTC-Me thiono-oxidation and testosterone 6beta-hydroxylation, weak inhibition by ketoconazole, troleandomycin, and anti-CYP3A antibodies suggested a minor role for CYP3A4; (3) a high correlation with immunoreactive CYP2B6 suggested involvement of this enzyme; (4) weak inhibition of DDTC-Me thiono-oxidation by furafylline and anti-CYP1A antibody suggested involvement of CYP1A2; and (5) inhibition of DDTC-Me thiono-oxidation by DDTC and anti-CYP2E antibodies suggested a role for CYP2E1. Collectively, these data suggested CYP3A4/5 enzymes are the major contributors to the sulfoxidation of DDTC-Me by human liver microsomes, and CYP1A2, CYP2B6, CYP2E1, and CYP3A4/5 contribute toward DDTC-Me thiono-oxidation by human liver microsomes. This study, in conjunction with others (Madan et al., Drug Metab. Dispos. 23:1153-1162, 1995), may help explain the variability in disulfiram's effectiveness as an alcohol deterrent.
二乙基二硫代氨基甲酸盐甲酯(DDTC-Me)是形成S-甲基-N,N-二乙硫代氨基甲酸盐亚砜的前体,该活性代谢产物被认为是双硫仑产生戒酒作用的原因。本研究调查了人细胞色素P-450(CYP)酶在DDTC-Me的硫氧化和硫酮氧化中的作用,这是双硫仑活化过程中的中间步骤。我们采用了几种方法来试图确定参与DDTC-Me硫氧化和硫酮氧化的特定P-450酶。这些方法包括使用cDNA表达的人P-450酶、与一组人肝微粒体中人类P-450酶的样本间差异进行相关性分析,以及化学和抗体抑制研究。如用cDNA表达的酶所测定,多种人P-450酶(CYP3A4、CYP1A2、CYP2A6和CYP2D6)催化了DDTC-Me的硫氧化。几条证据表明,人肝微粒体对DDTC-Me的硫氧化主要由CYP3A4/5催化,包括:(1)DDTC-Me硫氧化与睾酮6β-羟基化之间高度相关;(2)在CYP3A酶的激活剂α-萘黄酮存在下,DDTC-Me硫氧化增加;(3)CYP3A4/5酶的抑制剂,如醋竹桃霉素和酮康唑,抑制了该反应;(4)抗CYP3A酶抗体抑制了DDTC-Me硫氧化。另一方面,几条证据表明,人肝微粒体对DDTC-Me的硫酮氧化部分由CYP1A2、CYP2B6、CYP2E1和CYP3A4/5催化,包括:(1)如用cDNA表达的酶所测定,这些人P450酶以及其他酶有能力催化该反应;(2)DDTC-Me硫酮氧化与睾酮6β-羟基化之间高度相关,醋竹桃霉素、酮康唑和抗CYP3A抗体的弱抑制表明CYP3A4的作用较小;(3)与免疫反应性CYP2B6高度相关表明该酶参与其中;(4)呋拉茶碱和抗CYP1A抗体对DDTC-Me硫酮氧化的弱抑制表明CYP1A2参与其中;(5)DDTC和抗CYP2E抗体对DDTC-Me硫酮氧化的抑制表明CYP2E1起作用。总体而言,这些数据表明CYP3A4/5酶是人肝微粒体对DDTC-Me硫氧化的主要贡献者,而CYP1A2、CYP2B6、CYP2E1和CYP3A4/5参与了人肝微粒体对DDTC-Me的硫酮氧化。本研究与其他研究(Madan等人,《药物代谢与处置》23:1153 - 1162,1995)一起,可能有助于解释双硫仑作为戒酒药物有效性的变异性。